CAS 942123-43-5

Inarigivir soproxil

CAS: 942123-43-5

Inarigivir soproxil (SB9200) boosts innate immunity, combats HCV 1a/1b (EC50: 2.2/1.0 μM).

Formula: C₂₅H₃₄N₇O₁₃PS

Purity: 98.35%

Color and Shape: Solid

Molecular weight: 703.62

Ref: TM-T15573

Inarigivir soproxil

CAS: 942123-43-5

Formula: C₂₅H₃₄N₇O₁₃PS

Purity: %

Molecular weight: 703.6153

Ref: IN-DA01EOSX

Inarigivir soproxil

CAS: 942123-43-5

Inarigivir soproxil

Purity: ≥98%

Molecular weight: 703.62g/mol

Ref: 54-BUP04257

Inarigivir Soproxil

Controlled Product

CAS: 942123-43-5

Formula: C₂₅H₃₄N₇O₁₃PS

Color and Shape: Neat

Molecular weight: 703.615

Ref: TR-I627015

Inarigivir Soproxil

CAS: 942123-43-5

Inarigivir Soproxil is a viral replication inhibitor that targets the nucleocapsid protein of the virus. The drug inhibits viral replication by binding to the RNA strand, which blocks the synthesis of viral proteins and thus prevents the virus from reproducing. This drug binds to the viral RNA strand, preventing it from being translated into proteins. Inarigivir Soproxil has been shown to be effective against hepatitis A, B, and C viruses as well as HIV-1 strains that do not have a protease mutation. It has also shown efficacy in treating hepatitis C virus (HCV) infection in patients who are co-infected with HIV-1.

Formula: C₂₅H₃₄N₇O₁₃PS

Purity: Min. 95%

Molecular weight: 703.62 g/mol

Ref: 3D-SMB12343